{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:05:32Z","timestamp":1788786332493,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K11258"],"award-info":[{"award-number":["15K11258"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02994"],"award-info":[{"award-number":["18H02994"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Biosciences"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.job.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T02:37:13Z","timestamp":1557887833000},"page":"99-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Medication-related osteonecrosis of the jaw: A literature review"],"prefix":"10.1016","volume":"61","author":[{"given":"Shinichiro","family":"Kuroshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneteru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.job.2019.03.005_bib1","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.job.2019.03.005_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.job.2019.03.005_bib3","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2019.03.005_bib4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMcp1611090","article-title":"Management of acute hip fracture","volume":"377","author":"Bhandari","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.job.2019.03.005_bib5","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.job.2019.03.005_bib6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.2010.33.7485","article-title":"Use of bisphosphonates and reduced risk of colorectal cancer","volume":"29","author":"Rennert","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.job.2019.03.005_bib7","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1200\/JCO.2010.28.1113","article-title":"Use of bisphosphonates and risk of postmenopausal breast cancer","volume":"28","author":"Rennert","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.job.2019.03.005_bib8","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2010.28.2095","article-title":"Oral bisphosphonate use and breast cancer incidence in postmenopausal women","volume":"28","author":"Chlebowski","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.job.2019.03.005_bib9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.job.2019.03.005_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","article-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study","volume":"7","author":"Scagliotti","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.job.2019.03.005_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.job.2019.03.005_bib14","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib15","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.job.2019.03.005_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1254405","article-title":"Economic and social implications of aging societies","volume":"346","author":"Herpar","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.job.2019.03.005_bib17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3899\/jrheum.100221","article-title":"Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons","volume":"38","author":"Khan","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.job.2019.03.005_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00774-011-0299-z","article-title":"An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence","volume":"30","author":"Malden","year":"2012","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.job.2019.03.005_bib19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00784-012-0873-3","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment - a grossly underestimated risk?","volume":"17","author":"Hansen","year":"2013","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.job.2019.03.005_bib20","first-page":"151","article-title":"Medication related osteonecrosis of the jaw: 2015 position statement of the Korean society for bone and mineral research and the Korean association of oral and maxillofacial surgeons","volume":"22","author":"Kim","year":"2015","journal-title":"J\u00a0Bone Metab"},{"key":"10.1016\/j.job.2019.03.005_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2019.03.005_bib23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study","volume":"41","author":"Yamazaki","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.job.2019.03.005_bib25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/clr.12556","article-title":"Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials","volume":"27","author":"Boquete-Castro","year":"2016","journal-title":"Clin Oral Implant Res"},{"key":"10.1016\/j.job.2019.03.005_bib27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/clr.12088","article-title":"Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment","volume":"25","author":"Kwon","year":"2014","journal-title":"Clin Oral Implant Res"},{"key":"10.1016\/j.job.2019.03.005_bib28","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jcms.2016.09.018","article-title":"Clinical features of peri-implant medication-related osteonecrosis of the jaw: is there an association to peri-implantitis?","volume":"44","author":"Troeltzsch","year":"2016","journal-title":"J\u00a0Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib29","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.job.2019.03.005_bib31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","volume":"142","author":"Hellstein","year":"2011","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.job.2019.03.005_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00774-017-0872-1","article-title":"Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic\/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice","volume":"36","author":"Akita","year":"2018","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.job.2019.03.005_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2013.05.013","article-title":"Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice","volume":"56","author":"Kuroshima","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.job.2019.03.005_bib34","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2019.03.005_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jbmr.3292","article-title":"Transplantation of noncultured stromal vascular fraction cells of adipose tissue ameliorates osteonecrosis of the jaw-like lesions in mice","volume":"33","author":"Kuroshima","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2019.03.005_bib36","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.job.2019.03.005_bib37","article-title":"Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw","author":"Zhu","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.job.2019.03.005_bib38","first-page":"24","article-title":"Distinctive tooth-extraction socket healing: bisphosphonate versus parathyroid hormone therapy","volume":"85","author":"Kuroshima","year":"2014","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.job.2019.03.005_bib39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.job.2019.03.005_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.job.2019.03.005_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/en.2011-1439","article-title":"Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice","volume":"153","author":"Kuroshima","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.job.2019.03.005_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","article-title":"Giant osteoclast formation and long-term oral bisphosphonate therapy","volume":"360","author":"Weinstein","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.job.2019.03.005_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bone.2013.10.024","article-title":"Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients","volume":"59","author":"Jobke","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.job.2019.03.005_bib44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","article-title":"RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease","volume":"29","author":"Aghaloo","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2019.03.005_bib45","doi-asserted-by":"crossref","first-page":"37023","DOI":"10.1074\/jbc.M111.246280","article-title":"Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts","volume":"286","author":"Furuya","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.job.2019.03.005_bib46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00784-015-1550-0","article-title":"Mouse anti-RANKL antibody delays oral wound healing and increases TRAP-positive mononuclear cells in bone marrow","volume":"20","author":"Kuroshima","year":"2016","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.job.2019.03.005_bib47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-013-2570-8","article-title":"Early effects of parathyroid hormone on bisphosphonate\/steroid-associated compromised osseous wound healing","volume":"25","author":"Kuroshima","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.job.2019.03.005_bib48","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijom.2015.07.018","article-title":"Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings","volume":"44","author":"Kakehashi","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.job.2019.03.005_bib49","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A\u00a0systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.job.2019.03.005_bib50","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.job.2019.03.005_bib51","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1089\/scd.2012.0615","article-title":"Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine","volume":"22","author":"Li","year":"2013","journal-title":"Stem Cell Dev"},{"key":"10.1016\/j.job.2019.03.005_bib52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10103-016-1929-4","article-title":"Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review","volume":"31","author":"Weber","year":"2016","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.job.2019.03.005_bib53","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcms.2016.05.004","article-title":"Medication-related osteonecrosis of the jaw: is autologous platelet concentrate application effective for prevention and treatment? A systematic review","volume":"44","author":"Lopez-Jornet","year":"2016","journal-title":"J\u00a0Cranio-Maxillo-Fac Surg"}],"container-title":["Journal of Oral Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1349007919300477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1349007919300477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:13:54Z","timestamp":1778800434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1349007919300477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1349007919300477"],"URL":"https:\/\/doi.org\/10.1016\/j.job.2019.03.005","relation":{},"ISSN":["1349-0079"],"issn-type":[{"value":"1349-0079","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-related osteonecrosis of the jaw: A literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.job.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Association for Oral Biology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}